A0A1U9X7H8 (A0A1U9X7H8_HUMAN) Homo sapiens (Human)

Complement factor B UniProtKBInterProInteractive Modelling

764 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: P00751

Available Structures

25 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal Structure of Complement C3b in complex with Factors B and D Heteromer
P00746; P00751; P01024;
35-764
99.72NAG;NAG;MG;NAG;GOL;
Structure of the nanobody stablized properdin bound alternative pathway proconvertase C3b:FB:FP Heteromer
P00751; P01024; P27918;
35-764
99.86NAG;FUC;NAG;MAN;NAG;MG;
Crystal Structure of Complement C3b in Complex with Factor B Heteromer
P00751; P01024;
35-764
99.72NAG;NI;
Cobra Venom Factor (CVF) in complex with human factor B Heteromer
P00751; Q91132;
36-764
99.71NAG;NAG;MG;K;P6G;PO4;
Cobra Venom Factor (CVF) in complex with human factor B Heteromer
P00751; Q91132;
36-764
99.72NAG;NAG;MG;
Structure of the C3bB proconvertase in complex with lufaxin Heteromer
P00751; P01024; Q5WPU8;
36-764
100.0NAG;NAG;
Structure of the C3bB proconvertase in complex with lufaxin and factor Xa Heteromer
P00742; P00751; P01024; Q5WPU8;
36-764
100.0NAG;MG;NAG;
C3 convertase (C3bBb) stabilized by SCIN Heteromer
P00751; P01024; Q6GFB4;
260-764
100NAG;NAG;NAG;NAG;NAG;BMA;MAN;MG;NAG;
Structure of the SCIN stabilized C3bBb convertase bound to properdin Heteromer
P00751; P01024; P27918; Q931M7;
260-764
99.6FUC;NAG;NAG; 18×MAN;MG;
Structure of the SCIN stabilized C3bBb convertase bound to Properdin and a the non-inhibitory nanob… Heteromer
P00751; P01024; P27918; Q931M7;
260-764
99.6FUC;NAG;NAG; 21×MAN;MG;
Structure of the C3bBb-albicin complex Heteromer
A0A1Y9G8D0; P00751; P01024;
260-487
100.0NAG;NAG;
FACTOR B SERINE PROTEASE DOMAINhomo-2-mer470-764
100.0
Human Complement factor Bmonomer34-764
100.0NAG;NAG;NAG; 13×GOL;
Human Complement Factor B Inhibited by a Slow Off-Rate Modified Aptamer of 29 Basesmonomer34-764
100.0
Human Complement Factor B Inhibited by a Slow Off-Rate Modified Aptamer of 31 Basesmonomer34-764
100.0
Crystal Structure Analysis of the Bb segment of Factor Bmonomer268-764
99.38IOD;NA;CO;
Crystal Structure Analysis of the Bb segment of Factor B complexed with 4-guanidinobenzoic acidmonomer268-764
99.38IOD;NA;MG;GBS;
Crystal Structure Analysis of the Bb segment of Factor B complexed with Di-isopropyl-phosphate (DIP)monomer268-764
99.38IOD;NA;MG;DFP;
Complement factor B protease domain in complex with the reversible inhibitor N-(2-bromo-4-methylnap…monomer475-764
100.0SO4;JGT;
Complement factor B protease domain in complex with the reversible inhibitor 4-((2S,4S)-4-ethoxy-1-…monomer476-764
100.0SO4;JGQ;
Complement factor B in complex with (-)-4-(1-((5,7-Dimethyl-1H-indol-4-yl)methyl)piperidin-2-yl)ben…monomer476-764
100.0SO4;MVW;
Complement factor B protease domain in complex with the reversible inhibitor ((2S,4S)-1-((5,7-dimet…monomer476-764
100.0SO4;JGN;
Complement factor B in complex with (S)-5,7-Dimethyl-4-((2-phenylpiperidin-1-yl)methyl)-1H-indolemonomer476-764
100.0SO4;MVK;
Complement factor B in complex with 5-Bromo-3-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-7-methyl-1H-i…monomer477-764
100.0MVZ;SO4;
A domain of Factor Bmonomer268-476
99.48MN;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3hrz.1.Dmonomer0.8336-764
99.73